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Structural distribution of zinc(II) ions in the pore system of three silicate molecular sieves has revealed an
unprecedented application of the microporous titanosilicate Zn ETS 4 as a non toxic, highly efficient and
selective inhibitor of HeLa cancer cells.
1 Introduction
On an industrial scale, zeolites and related porous materials
have been extensively used as catalysts, ion exchangers,
adsorbents and detergent builders. Due to their ability for
reversible binding of small molecules such as oxygen and
nitric oxide alternative applications in medicine and pharmacy
have been also revealed.1–3 The size and shape selectivity of the
variety of microporous frameworks offer possibilities of
metalloenzyme mimicry, immunomodulatory activity,4 as well
as antibacterial and antiviral applications.5–9 Metal-exchanged
(Zn2+, Ag+, Cu2+) forms of microporous solids have been also
explored for active carriers of antibiotics and antimicrobial
applications.10–13 Medical investigations of zeolites as anti-
tumor agents are only known for mechanically treated natural
zeolite clinoptilolite that has been applied to several cancer
models.3 However, the strongest inhibition is achieved for
mouse fibrosarcoma cells, and for HeLa (human cervical
carcinoma cell line) cancer cells the reported value is less than
50%. In medicine, the antitumor effect of the Zn2+ ion is well
known,14–17 however the problem with the discrimination
between the cancer and the healthy cells remains one of the
most important challenges.18,19 Here, we show that Zn2+ ions
included in the pore system of the microporous titanosilicate
ETS-4 (Engelheart titanium silicate-4),20 transform the mate-
rial to a highly efficient and selective inhibitor of HeLa cancer
cells. The obtained solid (Zn–ETS-4), without affecting the
healthy cells, can reduce the tumor cells down to 5%. These
results are compared to another Zn-exchanged microporous
titanosilicate (STS-Sofia titanium silicate, also known as AM-2-
Aveiro-Manchester or synthetic umbite)21,22 and natural
clinoptilolite (CPT), which demonstrated that the specific host
of incorporation of Zn2+ is important for the efficiency and
selectivity of the antitumor effect. All these materials have also
been tested against HepG2 (human hepatocellular carcinoma
cell line) cancer cells, indicating a lower efficiency but still
superior cytotoxicity of Zn–ETS-4. Our findings discover new
options for application of the metal exchanged zeolites and
mixed tetrahedral–octahedral molecular sieves.
2 Experimental section
2.1 Synthesis and ion exchange
ETS-4 and STS were synthesized according to a previously
reported procedure.23 For structural determination and
elucidation of the positions of the Zn2+ ions, single crystals
of ETS-4 have been prepared.24 The source of natural
clinoptilolite (CPT) was the deposit of Beli plast, Kardzhali,
Bulgaria. The ion exchange was performed by immersing the
as-synthesized ETS-4, STS and CPT in 1 M solutions of ZnCl2
(Aldrich) for 3 days at 90 uC (30 days at 100 uC for CPT). Finally,
the samples were washed several times (5–7) by distilled water
(around 300 ml H2O per 0.5 g of solid product) and dried at
room temperature.
2.2 Characterization
The chemical composition was ascertained by energy-disper-
sive X-ray spectroscopy (EDAX-Pegasus X4M (EDS/EBSD) and
Zeiss LS 25) and inductively coupled plasma (ICP-Varian Vista
MPX CCD). The images were taken by NanoSEM-FEI Nova 200
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(FEG/SEM). The amount of hydroxyl species was determined
by thermogravimetry analyses (TGA) using Shimadzu TG-50 (in
air at the rate of 5 uC min 1) and Stanton Redcroft (in argon at
the rate of 5 uC min 1, 30–700 uC) analyzers. The powder XRD
analyses were collected on Bruker D8 Discover and Bruker D8
Advance diffractometers (Cu-Ka radiation, l = 1.5406 Å). The
single crystal data were collected on an Agilent Diffraction
SuperNovaDual four-circle diffractometer equipped with an
Atlas CCD detector using mirror-monochromatized Mo-Ka
radiation from a micro-focus source (l = 0.7107 Å).
2.2.1 Crystal data for K1.16Zn0.42TiSi3O9?2H2O (Zn–STS). M =
1469.96 g mol 1, monoclinic space group: P21/c (14), a = 7.205(9), b
= 10.034(2), c = 12.89(4) Å, b = 91.5(1)u, V = 931.9(9) Å3, rc = 2.6189(1) g
cm 3, Rp = 8.25, Rwp = 11.08, Rexp = 4.44, x
2 = 2.49, RB = 4.31.
2.2.2 Crystal data for (Na0.2Ca0.4K0.4Mg0.2)Zn2.2Al6Si30O72?19H2O
(Zn–CPT).M = 2646.68 gmol 1,monoclinic space group:C2/m (12), a
= 17.648(9), b = 17.963(1), c = 7.405(7) Å, b = 116.2(4)u, V = 2105.8(5) Å3,
rc = 2.0868(8) g cm
3, Rp = 4.17, Rwp = 5.39, Rexp = 2.92, x
2 = 1.83, RB =
1.53.
2.2.3 Crystal data for Zn3.15H4.76Si12Ti5O39?6.6H2O (Zn–ETS-4).
M = 1510.1(1) gmol 1, orthorhombic space group: Cmmm (65), a =
22.879(6), b = 7.2161(15), c = 6.765(2) Å, V = 1116.8(5) Å3, rc =
2.2450(4) g cm 3, m(Mo-Ka) = 2.913 mm 1, R1 = 0.127, wR2 = 0.292
(all data).
2.2.4 Cell cultures. The cell lines from hepatocellular
carcinoma (HepG2), cervical carcinoma (HeLa) and the non-
tumor cell line of murine fibroblasts (3T3) were used in this
study. The cells were grown in Dulbecco’s Modified Eagle’s
Medium (DMEM, Gibco-Invitrogen, UK) supplemented with
10% fetal calf serum (Gibco-Invitrogen, UK), 100 U ml 1
penicillin and 100 mg ml 1 streptomycin. All cell lines were
maintained at 37 uC in a 5% CO2 incubator. Cells were
subcultured regularly using trypsin–EDTA. All of the experi-
ments were carried out in the exponential phase of cell growth.
2.2.5 Cytotoxicity assay. A neutral red (NR) cytotoxicity assay
based on the protocol described by Borenfreund and Puerner25
was carried out. Briefly, cells were seeded in 96-well microtiter
plates (Scientific Orange) at 105 cells/well and allowed to
attach overnight. The cells were then treated for 24 h with
different concentrations of each zeolite: 0.667 mg ml 1, 0.445
mg ml 1, 0.296 mg ml 1, 0.198 mg ml 1, 0.132 mg ml 1, 0.088
mg ml 1, 0.058 mg ml 1 and 0.039 mg ml 1. For the
cytotoxicity assay, 100 ml of NR solution (50 mg ml 1) was
added to each well. After 3 h incubation at 37 uC and 5% CO2,
cells were destained with 100 ml of acetic acid (1%)–ethanol
(50%) (v/v). Untreated cells were used as controls, and wells
with a culture medium without cells were used as blank
controls. The optical density was measured at 570 nm with a
microplate reader (TECAN, SunriseTM, Austria). The viability
was represented as the percentage of viable cells after
preincubation with zeolites, as compared to the untreated
control group and was calculated for each concentration. The
percentage of inhibition of the cells was estimated as follows:
Cell viability (%) = OD570 (experimental)/OD570(control) 6
100. All experiments were performed in triplicate.
2.2.6 Statistical analysis. The results from treated and
control cells were compared using one-way analysis of variance
(ANOVA) followed by a Dunnett test. A P-value , 0.05 was
considered statistically significant. The concentration of each
zeolite which showed 50% cytotoxicity (IC50) was calculated.
The data were analyzed using GraphPad Prizm, GraphPad
Software Inc., USA, 2000. To identify statistically significant
differences, results were analyzed by the analysis of variance
using Dunnet’s Multiple Comparison Test. Probability values
of *p , 0.05, **p , 0.01, and ***p , 0.001 were considered
significant.
3 Results and discussion
3.1 Cytotoxic activity
In vitro cytotoxic activities of Zn–ETS-4, Zn–STS, Zn–CPT and
CPT have been tested by NR (neutral red) assay using HeLa
and HepG2 tumor cell lines and non-tumor cell line 3T3. NR is
a weak cationic dye that incorporates into the lysosomes of
living cells but not of damaged cells. Therefore the NR assay
provides a quantitative estimation of the number of viable
cells. Zn–CPT and Zn–ETS-4 showed significant cytotoxicity
(Fig. 1) to HeLa cells, when compared to the controls (P , 0.05
for each, one-way ANOVA). The IC50 values of Zn–CPT and Zn–
ETS-4 were 0.405 mg ml 1 and 0.543 mg ml 1, respectively.
Zn–CPT and Zn–ETS-4 exhibited high cytotoxic activity in a
very narrow concentration range—there was no reduction in
cell viability at lower concentrations but significant reduction
was induced at concentrations above 0.445 mg ml 1. At the
highest concentration (0.667 mg ml 1), about 95% loss of cell
viability was registered, however, cells remained more than
85% and 33.6% viable relative to the controls at concentration
0.445 mg ml 1 of Zn–ETS-4 and Zn–CPT, respectively. The
same materials applied to the HepG2 tumor cell line showed
lower cytotoxic activity. The viability of HepG2 cells treated
with Zn–ETS-4 was only slightly decreased—cells remained
more than 72% viable relative to controls, suggesting that Zn–
ETS-4 had low cytotoxicity to HepG2 cells, even at the highest
concentration of 0.667 mg ml 1. Zn–CPT did not affect the
HepG2 cell viability, indicating no cytotoxicity to this cancer
cell line. For comparison, we also determined the cytotoxicity
of each solid against non-tumor mammalian cells (3T3 cell
line). Zn–CPT induced 28% loss of 3T3 cell viability. No
cytotoxicity of Zn–ETS-4 was observed to non-tumor 3T3 cells
up to the highest concentration of 0.667 mg ml 1, demon-
strating high selectivity towards the tumor cells.
The natural non-modified CPT and the Zn-exchanged STS
did not affect the cell viability at all concentrations in all cell
lines used in the study, showing that they have no cytotoxic
activity (Fig. 1).
The obtained results clearly indicate that Zn–CPT can be
applied for selective inhibition of HeLa cancer cells while
sparing the HepG2 cells (Fig. 1). However, nowadays one of the
most important challenges is the development of anticancer
agents that can target cancer cells without affecting the
healthy tissue. In this aspect, Zn–ETS-4 shows more promising
behavior as it can suppress at the same time both cancer cell
lines (HeLa and HepG2), and in certain concentrations it
reduces the HeLa cancer cells down to 5% without any
cytotoxicity to the non-tumor cells of the 3T3 cell line.
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3.2 Crystal structure and zinc ion distribution of Zn–STS
A key to understanding antitumor properties is the interaction
of the Zn2+ ion with the microporous host. X-ray diffraction is
sensitive to local compositional and structural changes and
therefore provides insight into the possible reasons for the
different antitumor behaviour. Thus, upon ion exchange with
Zn2+, the crystal symmetry of STS changes from orthorhombic
(P212121) to monoclinic (P21/c). This type of conversion has
been previously described for other ion exchanged forms of
metal silicates with an umbite-like structure.26–28 The inclu-
sion of Zn2+ does not change the framework topology and it
remains a three-dimensional mixed framework with six- and
eight- ring channels. The primary building units are three
independent silicon atoms forming a trisilicate group Si3O9,
interconnected by one six coordinated (TiO6) titanium atom.
Fig. 1 Cell viability of HeLa, HepG2 and 3T3 cell lines assessed by the neutral red (NR) incorporation method. The molecular sieves Zn ETS 4, Zn CPT, Zn STS and CPT
were added at concentrations shown in the graphics (0.667 to 0.039 mg ml21) for 24 h. The NR assay was then performed. The relation between sample absorbance
and control absorbance calculated the relative absorbance.
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The ion exchange with Zn2+ altered the content and atomic
distribution in the voids. The electronic density over the 6-ring
channels showed one fully occupied K+ ion suggesting a lower
susceptibility for replacement. Analysis of site occupancy and
bond distances indicated that Zn2+ has an affinity to locate in
the bigger 8-ring channels where it partly substitutes K+ with a
composition of 0.42 Zn and 0.16 K (Fig. 2). In the same
channel the water molecules are found unevenly distributed
over the cation site and the two water positions. The high
isotropic parameters and some short Zn–Ow1 (1.711(4) Å) and
Ow1–Ow2 (water molecules) bond distances (1.781(1) Å)
suggest highly disordered Zn/H2O distribution. Considering
the presence of surface water, the detected 10.5% weight loss
is not far from the expected 2 water molecules per formula
unit (calculated 9.3%).
3.3 Crystal structure and zinc ion distribution of Zn–CPT
The natural CPT from Beli plast (Bulgaria) is well studied and a
comparison with previously published data29 indicated that
the ion exchange with Zn2+ did not change the framework
characteristics. Two Zn2+ sites (Zn1 and Zn3) in the 10-ring
channels and one (Zn2) in the 8-ring channels (Fig. 3) have
been found.30 Six independent sites corresponding to water
molecules have been also located. Two of them are situated in
the 8-ring and the other four are in the bigger 10-ring
channels.27 The refinement of the structure allowed the
detection of 18.98 water molecules per formula unit, however
the total weight loss of 14.44% pointed to more hydroxyl
species whose structural assignment was not possible.
3.4 Crystal structure and zinc ion distribution of Zn–ETS-4
The framework of ETS-4 is composed of chains of corner
sharing TiO6 octahedra running along the b-axis. These chains
are connected by SiO4 tetrahedra (along the c-direction) and
titanosilicate bridging units (along the a-axis) (Fig. 4). The
units are statistically distributed and determine the random
intergrowth of the four polymorphs that compose the frame-
work of ETS-4.31 The bridging units contain isolated titanium
atoms whose coordination environment has attracted various
studies. Originally, the single crystal X-ray diffraction study
from the natural analogue of ETS-4 indicated that mineral
zorite32 has a bridging unit composed of titanium semi-
octahedra where the Ti–O distance varies between 2.02 Å for
the basal and 1.67 Å for the apical oxygens. A later single
crystal investigation of Na–ETS-433 confirmed the five coordi-
nated titanium where the Ti–O distance varies between 1.96 Å
and 1.70 Å, respectively. The powder X-ray diffraction
Fig. 2 Crystal structure of Zn STS. SiO4 tetrahedra are bright (yellow) colored, Ti
octahedra are light (green) colored. For clarity the water molecules are omitted.
Fig. 3 Crystal structure of Zn CPT. Si/Al tetrahedra are bright (yellow) colored.
For clarity the water molecules are omitted.
Fig. 4 Crystal structure of Zn ETS 4 projected along c (up) and b (down) axes.
SiO4 tetrahedra are bright (yellow) colored, Ti octahedra are light (green)
colored. For clarity the water molecules are omitted.
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investigation of Na–ETS-434 and Sr–ETS-431 gave controversial
conclusions about the six-coordination of the titanium in the
bridging unit. While the Na–ETS-4 was claimed to have six-
coordinated titanium, in Sr–ETS-4 it was confirmed to have
five-coordinated titanium from the single crystal data. A recent
single crystal study of Ba-exchanged ETS-4 again suggested the
possibility of six-coordinated titanium in the bridging unit.24
Our results showed that Zn-exchanged crystals of ETS-4
possess titanosilicate bridging units where the titanium (Ti2)
is situated in the mirror plane (0, 0, K) and it has 50%
occupancy. It is coordinated by O5 (x, y, K) and O7 (0, 0, z).
The occupancy of O5 is K as is the bridging Si2, while the
apical O7 occupies J of the position. Thus, Ti2 can be
considered as five-coordinated. In the porous system of ETS-4
there are two independent cation positions.28–32 The first one
(Zn1) is situated in the 6-ring opening formed between two
TiO6 chains, and the second one (Zn2) is in the 7-ring channel
formed between the titanosilicate bridging units and TiO6
chains (Fig. 4). No Zn atoms are positioned in the 8-ring
channels propagating along the b-axis. Zn1 has an occupancy
of 0.85 and Zn2 of about 0.18. This means that around the
bridging units there are highly charged unsaturated zones and
charge-balancing protons are required. Similarly to Na1 in Na–
ETS-4,33,34 Zn1 is eight-coordinated by two water molecules
and six oxygens. However, Zn2 shows coordination of five
oxygens which differ from the seventh coordination observed
for this position in the Sr– and Na–ETS-4.31,34 The water
molecules in Zn–ETS-4 occupy three sites that are disordered
over the 6-ring openings (O21) and the 8-ring channels (O22
and O23), corresponding to 6.62 water molecules per formula
unit (8%). This amount is less than the estimated 12.6%
weight loss which supports the presence of a number of
hydrogen connected oxygens.
The obtained results clearly indicate that the complete ion
exchange without a full population of Zn2+ ions can introduce
charge unsaturated zones within the structure of ETS-4. This
can bring a partial collapse of the defected framework units
(titanosilicate bridging units) and as a result polymorph
enriched zones are formed. This suggestion is supported by
the powder XRD pattern of Zn–ETS-4 (Fig. S5, ESI3) whose extra
reflections can be assigned to the previously reported
orthorhombic polymorph of the phase.31
The structural elucidation showed that the increased
amount of incorporated Zn2+ ions per formula unit (ETS-4
(13.4 wt.%) . STS (7.13 wt.%) . CPT (5.63 wt.%)) is not
proportional to the efficiency and selectivity of the anticancer
process. The material with the intermediate amount of Zn2+
showed no effect on the cancer cells used and the solids with
the lowest and highest quantity of Zn2+ demonstrated a similar
efficiency but different selectivities against HeLa cells. While
Zn–CPT is the most efficient, Zn–ETS-4 is the most selective
inhibitor of HeLa cancer cells. These findings indicate the
major role of specific host accommodation of Zn2+ for the
efficiency and selectivity of the antitumor process. In the
literature the antitumor effect of the Zn2+ ion is well known,
however the exact mechanism of action is not completely
understood. There are reports suggesting that zinc may protect
normal cells against DNA-damaging action and increase this
action in cancer cells, which indicates the dual action of this
element in the dependency on target cells.35 From our results
it is clear that the specific host accommodation of Zn2+ ions
can provide selective cytotoxicity towards certain cancer cell
lines. The zinc ion in ETS-4 occupies two positions and resides
in relatively narrow channels when compared to STS and CPT.
This can be a clue as to where to further search for proper
carriers of metal ions.
To date, the zeolite based treatment of cancer cells is limited
to natural micronized clinoptilolite, showing influence on the
proliferation and survival of cancer cell lines of human origin.3
It is suggested that clinoptilolite inhibited cell proliferation
due in part to the induction of inhibitors of cyclin-dependent
kinases, inhibition of B/Akt expression, induced expression of
p21WAF1/CIP1 and p27KIP1 tumor suppressor proteins, and
subsequent programmed cell death.3,36 However, in our work
the non-modified natural clinoptilolite did not show any
cytotoxic activity (Fig. 1) which can originate from differing
particle size or chemical composition. The natural origin of
the CPT presumes a chemical composition determined by the
specific conditions of the deposit and for better understanding
of the observed effect further cytotoxic studies should be
performed on synthetic molecular sieves.
4 Conclusions
In this study we extend the known applications of the metal
exchanged molecular sieves by introducing the selective
anticancer effect of a Zn2+ loaded microporous host. A crystal
structure study and in vitro tests on cancer (HeLa, HepG2 cell
lines) and non-cancer (3T3 cell line) cells reveal that the
specific microporous system tends to control the selectivity
and efficiency of the anticancer properties of the zinc ion.
Thus, Zn2+ incorporated in the six- and seven-ring channels of
ETS-4 transform the solid into a highly selective and efficient
inhibitor of HeLa and HepG2 cancer cells, while sparing the
healthy ones. On the contrary, the zinc ions in the eight- and
ten-ring channels of the clinoptiolite convert the solid to an
efficient but not selective inhibitor of HeLa cancer cells. Zinc
exchanged eight-ring channels of STS and non exchanged
clinoptiolite show no influence on the studied cancer cell
lines. We anticipate that the presented results will instigate
studies on other cancer genotypes targeted by various metal
exchanged molecular sieves.
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